Josep Bassaganya-Riera - Feb 28, 2023 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
10%+ Owner
Signature
Josep Bassaganya-Riera
Stock symbol
LABP
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 08:02 PM
Previous filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LABP common stock Sale -3.47M -100% 0 Feb 28, 2023 by trust F1, F2
transaction LABP common stock Sale -467K -100% 0 Feb 28, 2023 by GRAT F1, F3
transaction LABP common stock Sale -497K -100% 0 Feb 28, 2023 by GRAT F1, F4
transaction LABP common stock Sale -500K -100% 0 Feb 28, 2023 by GRAT F1, F5
transaction LABP common stock Sale -786K -100% 0 Feb 28, 2023 by family trust F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Josep Bassaganya-Riera is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 All of the shares reported as sold on this Form 4 were sold to the issuer for aggregate consideration of $1,888,814.77 in cash plus certain intellectual property rights and other assets, as part of the private transaction described in the issuer's Current Report on Form 8-K filed on February 28, 2023 with the Securities and Exchange Commission.
F2 These shares were held by the Josep Bassaganya-Riera Revocable Trust dated April 9, 2018, as amended (the "2018 Trust"). The Reporting Person is the sole trustee of the 2018 Trust and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F3 These shares were held by the Josep Bassaganya-Riera Grantor Retained Annuity Trust No. 1 dated June 28, 2018 (the "2018 GRAT"). The Reporting Person is the sole trustee of the 2018 GRAT and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F4 These shares were held by the Josep Bassaganya-Riera Grantor Retained Annuity Trust No. 2 dated March 26, 2019 (the "2019 GRAT"). The Reporting Person is the sole trustee of the 2019 GRAT and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F5 These shares were held by the Josep Bassaganya-Riera Grantor Retained Annuity Trust No. 3 dated August 3, 2022 (the "2022 GRAT"). The Reporting Person is the sole trustee of the 2022 GRAT and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F6 These shares were held by the Raquel Hontecillas-Magarzo Irrevocable Family Trust dated October 1, 2021 (the "2021 Family Trust"). The Reporting Person is the sole trustee of the 2021 Family Trust and the beneficiaries are the Reporting Person and the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.